1. Academic Validation
  2. Evaluation of an automated chromogenic substrate assay for the rapid determination of hirudin in plasma

Evaluation of an automated chromogenic substrate assay for the rapid determination of hirudin in plasma

  • Thromb Res. 1995 Jan 15;77(2):165-73. doi: 10.1016/0049-3848(95)91622-r.
G Hafner 1 K Fickenscher H J Friesen H J Rupprecht U Konheiser W Ehrenthal J Lotz W Prellwitz
Affiliations

Affiliation

  • 1 Institute of Clinical Chemistry and Laboratory Medicine, Johannes Gutenberg-University Mainz, Germany.
Abstract

A fully mechanized chromogenic substrate assay method for the rapid and specific determination of recombinant hirudin (r-hirudin) in citrated plasma on clinical chemistry analyzers (Hitachi 911 and Cobas Mira) is described. In a first step, 12 microliters sample volume is mixed with the chromogenic substrate. Due to the almost immediate action of hirudin the inhibitory reaction and the cleavage of the substrate is started simultaneously when bovine Thrombin is added in excess. This excludes interferences by Antithrombin III or Heparin Cofactor II. The change in absorbance/min is recorded at 405 nm. The measuring range is about 0.2-4.0 mg/l r-hirudin on both analyzers. Precision is characterized by intraassay coefficients of variation between 0.63% and 2.78% on the Hitachi 911 and 1.51% and 7.84% on the Cobas Mira, respectively and interassay coefficients of variation of 3.57% to 9.15% (Hitachi 911) and 3.72% to 12.99% (Cobas Mira) for the same r-hirudin plasma concentrations. The described determination of r-hirudin correlates well with an Enzyme linked immunosorbent assay method for r-hirudin (Hitachi 911: r = 0.964, y = 0.978x + 0.038, n = 323; Cobas Mira: r = 0.964, y = 0.959x-0.003, n = 323).

Figures
Products